Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cancer Care Reviews – a guide The Cancer Care Review (CCR) has been modelled on a template which has been piloted and evaluated by Macmillan. The patients surveyed were very positive about the process of a review, with over 71% being ‘very satisfied’ with the process. Patients felt that the CCR gave them an opportunity to discuss their cancer and general state of health with their GP and appreciated the fact that their GP made the effort to contact them. Why do we need this? Cancer survivors often describe the end of the active phase of their diagnosis and treatment as being like falling off a cliff. The admissions and appointments cease and there can be no point of reference, there is no one to turn to with their concerns; people with cancer often feel lonely and cut adrift. The review enables the GP practice to proffer a helping hand and to compliment the service provided by the Cancer CNSs (Clinical Nurse Specialists) working within secondary care. Salford Royal is proactive in the survivorship field; the Breast Service provides a 4 week “Moving Forward” program, there is a similar Health and Wellbeing event for all tumour groups and the CANMOVE program promotes the benefits of regular exercise. The emphasis of the review is not about making complex treatment decisions; clearly keeping abreast of the rapidly evolving treatment paradigms which are the norm in the cancer field is well outside a GP’s role. What the review is about is giving the patient an opportunity to air their concerns and taking a holistic approach to their problems. It really should not be viewed as a tick box exercise but rather the patient should be allowed to set the agenda. The template is a guideline not a tramline, this review should be “owned” by the patient. To facilitate this it is suggested, though it is not mandatory, that the “Concerns Checklist” is sent to the patient prior to the appointment. This lists the common problems which face the cancer survivor; few escape its pinch unscarred. Some of the problems listed are ones which primary care is adept at managing, for example most GPs are confident at managing many of the physical and mental issues health mentioned. There are, however, several areas outside the competence of most family doctors where the appropriate response is to signpost to other services and resources. The following guidance about the individual items in the Salford Standard template may be helpful; in general terms it is suggested that open questions are used rather than narrow, specific ones. The order in which the questions are approached is not mandated and practitioners are free to tackle the issues in any way they see fit. READ CODE 8B3V 1. Reviewing any medication the patient is taking for their condition It is not expected that the GP should be familiar with the medication prescribed in secondary care; however he/she does have a responsibility for the medication prescribed by the GP practice. With respect to Breast and Prostate cancer this is an ideal opportunity to consider medication such as Gonadotropin-releasing hormone analogues (Zoladex, Prostap etc), Tamoxifen and Aromatase inhibitors. As well as discussing adverse symptoms the effect of these agents on bone health and cardiovascular risk should be discussed. The NICE guidance on Osteoporosis states: 1.8 Consider measuring BMD with DXA before starting treatments that may have a rapid adverse effect on bone density (for example, sex hormone deprivation for treatment for breast or prostate cancer). An initial DEXA scan will probably have been performed either before treatment has started or shortly after; there is a case for considering bone density measurement every two years in patients on long term Gonadotropin-releasing hormone analogues and Aromatase inhibitors. The risk factors for cancer are the same as for cardiovascular disease demonstrated by the fact that breast cancer sufferers are 50% more likely to suffer a stroke than matched controls. The Gonadotropin-releasing hormone analogues cause weight gain and have an adverse effect on lipid profile. Practices may wish to arrange a cardiovascular risk assessment as part of the Cancer Care Reviews. Hot flushes can be a debilitating adverse effect of the Gonadotropin-releasing hormone analogues. NICE guidance 1 suggests treatment with Medroxyprogesterone or Cyproterone acetate READ CODES 677H and 80AQ 2. Providing the patient with information about cancer The Salford Macmillan Information & Support Centre is a drop in service that is open Monday to Friday from 9am to 5pm. The service provides free information and support to anyone affected by or living with cancer, there is wide range of information available about; specific cancers and their treatments, living with cancer eg fatigue, diet, financial issues, work, travel and emotional support. As well as providing free information resources the service also runs a numbers of support groups and other services including Look Good Feel Better, Headstrong, Health Walks, Cancer Health & Well Being program and a volunteer driver scheme. The service can be contacted by: Phone: 0161 206 1455 Email: [email protected] Address: Salford Macmillan Information & Support Service Salford Royal Hospital Stott Lane Salford M6 8HD There is also great deal of information available for people affect by cancer available on the internet, however the quality and reliability of this can be variable for this reason it is recommended that to signpost the following sources; http://www.macmillan.org.uk/information-and-support/index.html http://www.cancerresearchuk.org/about-cancer/ http://www.christie.nhs.uk/patients-and-visitors/your-treatment-and-care/patientinformation/ https://www.breastcancercare.org.uk/information-support https://www.beatingbowelcancer.org/booklets-factsheets http://www.roycastle.org/how-we-help/lung-cancer-information http://prostatecanceruk.org/prostate-information 3. Providing information or signposting to sources of information about benefits the patient may be entitled to 1 https://www.nice.org.uk/guidance/cg175/chapter/1-recommendations The Salford Macmillan Information & Support Centre has a weekly CAB clinic for people affected by cancer. The centre is also able to help with Macmillan Grants, these are means tested grants of up to £400 for people living or beyond cancer. http://be.macmillan.org.uk/Downloads/CancerInformation/FinancialSupport/MAC4026HWTC OCe1320150501.pdf This free booklet is available to order via www.be.macmillan.org.uk READ Code 918A 4. Recording the details of any carer(s) who are supporting the patient Cancer does not just affect the patient. GPs will be well aware how illness impacts on families READ CODE 8BAV 5. Discussing the patient’s cancer diagnosis It is important to understand where the patient sees themselves on their journey and there can often be dissonance between what is said in hospital letters and what is believed by the patient. Questions such as “What have the hospital said about your illness?” can be useful. Is the patient aware that they have cancer or in denial? It is not necessary to challenge erroneous beliefs but discussion with secondary care might be appropriate. In general terms most patients will fall into one of the following groups: a) Have undergone curative treatment but where there is a chance of recurrence. b) Have a cancer which is incurable but treatable eg locally invasive Prostate cancer receiving Gonadotropin-releasing hormone analogues. c) Have primary or recurrent cancer which is active and progressive and treatment is being given to attempt cure or improve prognosis. d) Receiving palliative care. Patients will often have questions about their illness; if the practitioner does not know the answer then the resources listed above may be helpful. 6. Anything else? If the Concerns Checklist is used then it is probably best used here. If you need to “phone a friend” for advice then the following numbers may be useful2 Salford Royal Urology CNS Team 0161 206 5380 Salford Royal Breast CNS Team 0161 206 2224 (all patients will have a key worker who can be identified via this number) The sorts of problems the CNSs can help with or can access help for include: Erectile dysfunction Severe psychological distress Lymphoedema Body image/relationship issues Incontinence 2 For patients not receiving care from Salford Royal FT contact details of CNSs will probably be on hospital letters via consultant’s secretary. Shoulder problems after treatment for breast cancer The fear of recurrence is one which haunts many cancer survivors. If the practitioner feels that there is evidence of recurrence then if the patient is still under Salford Royal then the CNS team should be contacted but if the patient has been discharged then a new ? cancer TWW referral should be made For Breast patients “red flags” would include: A palpable lump Weight loss Upper body or spinal bone pain Persistent or escalating headache For Prostate patients “red flags” would include: Visible haematuria New onset of bone related pain PSA double time <3 months Lymphodeama Be aware of DVT and Pulmonary Embolism risk Acute retention of urine Metastatic Spinal Cord Compression (MSCC) is a recognised complication of both Breast and Prostate cancer – the Red flags are: Referred pain that is multi-segmental or band-like Escalating pain which is poorly responsive to treatment (incl medication) Different character or site to previous symptoms Funny feelings, odd sensations or heavy legs (multi-segmental) Lying flat increases pain Agonising pain causing anguish and despair Gait disturbance, unsteadiness, especially on stairs (not just a limp) Sleep grossly disturbed due to pain being worse at night Remember: Established motor/sensory/bladder/bowel disturbances are late signs of MSCC and that MSCC is a neurosurgical emergency (Taken from Greenhalgh S, Turnpenney J, Richards L, Selfe J (2010) Steven Elliot Macmillan GP 15 March 2016